{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:08:49Z","timestamp":1750910929354,"version":"3.41.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Health and Labor Sciences Research Grants"},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Rapid decline in estimated glomerular filtration rate (eGFR) is linked to increased mortality and morbidity in chronic kidney disease (CKD). Few studies have focused on the risk of rapid eGFR decline. This study evaluates the association between antihypertensive drug use, blood pressure (BP) levels, and rapid eGFR decline in Japanese CKD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Data from 100,746 Japanese individuals aged 40\u201374 years with CKD were analyzed. Rapid eGFR decline was defined as an annual reduction\u2005&amp;gt;\u200525%. Logistic regression was used to assess associations between antihypertensive drug use, BP levels, and rapid eGFR decline, stratified by eGFR and urinary proteinuria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Rapid eGFR decline occurred in 5.8% of participants. Higher BP levels increased the risk compared to normal BP: high-normal\u2005+\u2005elevated BP (odds ratio [OR], 1.26; 95% CI: 1.12\u20131.41) and high BP (OR, 1.79; 95% CI: 1.59\u20132.02). Controlling BP to high-normal or elevated levels in patients receiving antihypertensives reduced this risk. Overall, antihypertensive drug users had approximately twice the risk of rapid eGFR decline compared to nonusers. However, in proteinuric patients with preserved eGFR, the risk increase was lower (1.27 times) in the high-normal\u2005+\u2005elevated BP group compared to that in the overall cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The risk of rapid eGFR decline increased with increasing BP and decreased with controlling BP. Antihypertensive treatment was associated with a higher risk of rapid eGFR decline at all BP levels. For CKD patients with proteinuria, maintaining BP in the high-normal or elevated range may further mitigate this risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpaf041","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T07:02:53Z","timestamp":1743231773000},"page":"476-484","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Antihypertensive Drugs on Rapid Decline in Estimated Glomerular Filtration Rate in Japanese Patients With Chronic Kidney Disease"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4258-3692","authenticated-orcid":false,"given":"Kenta","family":"Fujimoto","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki , Miyazaki ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki , Miyazaki ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michikazu","family":"Nakai","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, University of Miyazaki Hospital , Miyazaki ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Konta","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunitoshi","family":"Iseki","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-2928","authenticated-orcid":false,"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7407-0410","authenticated-orcid":false,"given":"Kunihiro","family":"Yamagata","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Moriyama","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Kasahara","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Kondo","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Asahi","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Kaikita","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki , Miyazaki ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouichi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki , Miyazaki ,","place":["Japan"]},{"name":"Steering Committee of The Japan Specific Health Checkups (J-SHC) Study , Fukushima ,","place":["Japan"]},{"name":"M&N Collaboration Research Laboratory, Department of Medical Environment Innovation, Faculty of Medicine, University of Miyazaki , Miyazaki ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,23]]},"reference":[{"key":"2025062515073481000_CIT0001","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"The Lancet"},{"key":"2025062515073481000_CIT0002","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/kisup.2012.65","article-title":"Chapter 2: Definition, identification,","volume":"3","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"key":"2025062515073481000_CIT0003","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1093\/ndt\/gfs263","article-title":"Short-term change in kidney function and risk of end-stage renal disease","volume":"27","author":"Turin","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2025062515073481000_CIT0004","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000339289","article-title":"One-year change in kidney function is associated with an increased mortality risk","volume":"36","author":"Turin","year":"2012","journal-title":"Am J Nephrol"},{"key":"2025062515073481000_CIT0005","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1053\/j.ajkd.2008.05.030","article-title":"Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan","volume":"52","author":"Cheng","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2025062515073481000_CIT0006","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1001\/archinte.168.20.2212","article-title":"Rapid kidney","volume":"168","author":"Rifkin","year":"2008","journal-title":"Arch Intern Med"},{"key":"2025062515073481000_CIT0007","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1681\/ASN.2009050546","article-title":"Rapid decline of kidney function increases cardiovascular risk in the elderly","volume":"20","author":"Shlipak","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025062515073481000_CIT0008","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1681\/ASN.2009121210","article-title":"Rate of kidney function decline associates with mortality","volume":"21","author":"Al-Aly","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2025062515073481000_CIT0009","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1681\/ASN.2009010025","article-title":"Change in estimated GFR associates with coronary heart disease and mortality","volume":"20","author":"Matsushita","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025062515073481000_CIT0010","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"key":"2025062515073481000_CIT0011","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1007\/s10157-017-1392-y","article-title":"Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008\u20132012","volume":"21","author":"Iseki","year":"2017","journal-title":"Clin Exp Nephrol"},{"key":"2025062515073481000_CIT0012","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2025062515073481000_CIT0013","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"2025062515073481000_CIT0014","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"2025062515073481000_CIT0015","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJM198903163201110","article-title":"The kidney in hypertension \u2014 villain and victim","volume":"320","author":"Klahr","year":"1989","journal-title":"N Engl J Med"},{"key":"2025062515073481000_CIT0016","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"2025062515073481000_CIT0017","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","article-title":"Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup","volume":"13","author":"Chawla","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2025062515073481000_CIT0018","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000516647","article-title":"Defining AKD: the spectrum of AKI, AKD, and CKD","volume":"146","author":"Levey","year":"2022","journal-title":"Nephron"},{"key":"2025062515073481000_CIT0019","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/MNH.0000000000000920","article-title":"Blood pressure targets in chronic kidney disease: still no consensus","volume":"32","author":"Lucas","year":"2023","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2025062515073481000_CIT0020","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann Intern Med"},{"key":"2025062515073481000_CIT0021","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/HYPERTENSIONAHA.113.03206","article-title":"Cardiovascular risk with and without antihypertensive drug treatment in the Japanese general population","volume":"63","author":"Asayama","year":"2014","journal-title":"Hypertension"},{"key":"2025062515073481000_CIT0022","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/HJH.0b013e32831967ca","article-title":"Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study","volume":"27","author":"Asayama","year":"2009","journal-title":"J Hypertens"},{"key":"2025062515073481000_CIT0023","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41440-019-0220-z","article-title":"Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study","volume":"42","author":"Harada","year":"2019","journal-title":"Hypertens Res"},{"key":"2025062515073481000_CIT0024","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"2025062515073481000_CIT0025","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41581-020-0253-1","article-title":"Strategies to prevent kidney disease and its progression","volume":"16","author":"Kalantar-Zadeh","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2025062515073481000_CIT0026","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/ndt\/gfad271","article-title":"Risk factor analysis for a rapid progression of chronic kidney disease","volume":"39","author":"Vestergaard","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2025062515073481000_CIT0027","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.kint.2023.01.008","article-title":"Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function","volume":"103","author":"Imaizumi","year":"2023","journal-title":"Kidney Int"},{"key":"2025062515073481000_CIT0028","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.2174\/1381612811319170009","article-title":"Angiotensin II blockade and renal protection","volume":"19","author":"Kobori","year":"2013","journal-title":"Curr Pharm Des"},{"key":"2025062515073481000_CIT0029","doi-asserted-by":"publisher","first-page":"j791","DOI":"10.1136\/bmj.j791","article-title":"Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study","volume":"356","author":"Schmidt","year":"2017","journal-title":"BMJ"},{"key":"2025062515073481000_CIT0030","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05090418","article-title":"Ptolemy and copernicus revisited: the complex interplay between the kidneys and heart failure","volume":"13","author":"Coca","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025062515073481000_CIT0031","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor\u2013associated elevations in serum creatinine","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"key":"2025062515073481000_CIT0032","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2215\/CJN.02780319","article-title":"Urine markers of kidney tubule cell injury and kidney function decline in SPRINT Trial participants with CKD","volume":"15","author":"Malhotra","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025062515073481000_CIT0033","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2215\/CJN.12051115","article-title":"Association of urinary biomarkers of inflammation, injury, and fibrosis with renal function decline: The ACCORD Trial","volume":"11","author":"Nadkarni","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025062515073481000_CIT0034","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaf041\/62650637\/hpaf041.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/38\/7\/476\/62650637\/hpaf041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/38\/7\/476\/62650637\/hpaf041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:07:37Z","timestamp":1750878457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/38\/7\/476\/8092976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,23]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,3,23]]},"published-print":{"date-parts":[[2025,6,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaf041","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"type":"print","value":"0895-7061"},{"type":"electronic","value":"1941-7225"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,23]]}}}